Website intended for a NZ health professional readership
Consultant cardiologist Chris Ellis weighs up the options for assessment of cardiovascular disease risk
1. Aroney C. Should coronary calcium scoring be used as the central tool for cardiac risk assessment? Heart Lung Circ 2019;28(2):207–12.
2. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41(1):111–88.
Prostate cancer consultations are common in primary care and there is no one approach to testing and treatment that fits all patients. Urologist Simon van Rij discusses the key considerations and options for personalised care, appropriate investigation and treatment
